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Combined Natural Killer Cell and Dendritic Cell
Functional Deficiency in KARAP/DAP12
Loss-of-Function Mutant Mice
polypeptides and their associated receptors are critical
for the formation of these functional oligomeric com-
plexes. The group of ITAM-bearing polypeptides in-
cludes CD3 molecules (CD3g, CD3d, CD3e) associated
with the T cell receptor complex (TCR), Ig-a and Ig-b
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Ig-like signal regulatory protein b1 (SIRP-b1), TREM-1
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an intracytoplasmic immunoreceptor tyrosine-based still unveiled (Dietrich et al., 2000; Tomasello et al., 2000;
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with several activating cell surface receptors in hema- ITAM-bearing polypeptides couple cell surface recep-
topoietic cells. Here, we report that knockin mice bear- tors to signaling pathways that depend on protein tyro-
ing a nonfunctional KARAP/DAP12 ITAM present al- sine kinases (PTKs), and integrity of the ITAM sequence
tered innate immune responses. Although in these mice is mandatory for the signaling function of these trans-
NK cells are present and their repertoire of inhibitory duction polypeptides (Love and Shores, 2000). To dis-
MHC class I receptors is intact, the NK cell spectrum sect the role of oligomeric complexes that associate
of natural cytotoxicity toward tumor cell targets is re- with KARAP/DAP12, we generated KARAP/DAP12 loss-
stricted. KARAP/DAP12 loss-of-function mutant mice of-function mutant mice (KDY75/KDY75), in which the
also exhibit a dramatic accumulation of dendritic cells KARAP/DAP12 ITAM is nonfunctional. We describe here
in muco-cutaneous epithelia, associated with an im- the alterations of NK and dendritic cell (DC) subsets
paired hapten-specific contact sensitivity. Thus, de- observed in KDY75/KDY75 mice.
spite its homology with CD3z and FcRg, KARAP/DAP12
plays a specific role in innate immunity, emphasizing
Resultsthe nonredundancy of these ITAM-bearing polypep-
tides in hematopoietic cells.
Generation of KARAP/DAP12 Knockin Mice
In vitro studies using mutant KARAP/DAP12 have shownIntroduction
that both Y residues in ITAMs are necessary for KARAP/
DAP12 signaling function (Tomasello et al., 1998). WeThe consensus intracytoplasmic ITAM sequence, YxxL/
thus designed a KARAP/DAP-12 knockin strategy inIx6-8YxxL/I (Reth, 1989; Wegener et al., 1992), has led to
which the mutated KARAP/DAP12 protein lacks the Y75the identification of a group of ITAM-bearing transduc-
residue and wild-type C terminus amino acids (KDY75tion polypeptides that are associated with multiple cell
protein). A homologous recombination targeting vectorsurface receptors. Single charged amino acid residues
was constructed by inserting a neo-resistance cassettein the transmembrane domains of both ITAM-bearing
flanked by two lox P sites at the unique XcaI restriction
site (Figure 1A). In order to obtain KDY75/KDY75 mice,7 To whom correspondence should be addressed (e-mail: vivier@
ES cells were transfected with the targeting constructionciml.univ-mrs.fr [E. V.], kaiserlian@lyon151.inserm.fr [D. K.]).
8 These authors contributed equally to this work. (Figure 1B) and recombinant ES clones were injected in
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Figure 2. Expression of Activating and Inhibitory MHC Class I Re-
ceptors on Splenic NK Cells Isolated from Control and KDY75/
KDY75 Mice
(A) The cell surface expression of indicated receptors on CD32DX51
splenic NK cells isolated from control mice (upper panels) andFigure 1. Generation of KDY75/KDY75 Knockin Mice
KDY75/KDY75 mice (lower panels) was analyzed by flow cytometry.(A) The exon/intron organization of mouse KARAP/DAP12 gene in
The percentages of positive stained cells (continuous lines) as wellthe 129 background is schematized (top; E, exon), and the corre-
as the control staining using isotype-matched control mAbs (dottedsponding KARAP/DAP12 protein is also represented (bottom; LP,
lines) are indicated.leader peptide; EC, extracellular domain; TM, transmembrane do-
(B) (Left panel) 7 days cultured IL-2 activated DX51 splenocytes weremain; and IC, intracellular domain). KARAP/DAP12 ITAM is centered
analyzed in a 4 hr 51Cr release assay against the murine mastocytomaon tyrosine residues Y65 and Y75, as indicated (shaded area).
P815 (FcgR1) in the presence (anti-Ly49D) or absence (control) of(B) KARAP/DAP12 targeting strategy.
anti-Ly49D mAbs at the 2.5:1 E:T ratio. Control mice, open bars;(C) Southern blot analysis. The 9.2 kb wild-type and the 1.8 kb targeted
KDY75/KDY75 mice, filled bars. (Right panel) 7 days cultured IL-2allele EcoRI-EcoRI fragments identified by probe E are indicated.
activated DX51 splenocytes were analyzed in a 4 hr 51Cr release(D) RT-PCR analysis of 1/1, 1/KDY75, and homozygous mutant
assay against CHO tumor cell lines at the indicated E:T ratios. Con-(KDY75/KDY75) littermates.
trol mice, open circles; KDY75/KDY75 mice, filled circles.
Balb/c blastocysts. Recombinant offspring of chimeric numbers of lymphoid and myeloid subsets were de-
mice was crossed with Cre mice transgenic, generat- tected using immunofluorescent flow cytometry analy-
ing “floxed” 1/KDY75 mice (Figure 1B). Heterozygous sis when peripheral blood mononuclear cells (PBMCs)
1/KDY75 mice were mated to obtain KDY75/KDY75 from 1/1, 1/KDY75, and KDY75/KDY75 mice were com-
mice, and offspring was analyzed by Southern blot (Figure pared (data not shown).
1C). To confirm the replacement of wild-type KARAP/
DAP12 by KDY75, RT-PCR amplification was performed NK Cell Repertoire of Ly49 Molecules in the Presence
on total splenocytes RNA prepared from 1/1, 1/KDY75, of Nonfunctional KARAP/DAP12 Molecules
and KDY75/KDY75 mice. As shown in Figure 1D, amplifi- In mouse NK cells, association with KARAP/DAP12 has
cation of wild-type KARAP/DAP12 cDNA was absent in been shown to be required for the cell surface expres-
KDY75/KDY75 mice and substituted with a band of sion of Ly49D and of Ly49H (Smith et al., 1998). No
larger size (due to the presence of one loxP site). The significant alteration in the reactivity of anti-Ly49D mAb
DAP-10 transduction protein is encoded by a gene lo- (4E5) and of anti-Ly49H mAb (3D10) was observed when
cated at z100 bp of the KARAP/DAP12 gene in a tail- splenic NK cells derived from KDY75/KDY75 mice and
to-tail orientation (Chang et al., 1999; Wu et al., 1999). from control mice were compared (Figure 2A), consis-
RT-PCR analysis of DAP-10 expression was similar in tent with the cell surface association of KDY75 with
1/1, 1/KDY75, and KDY75/KDY75 mice (Figure 1D), Ly49D and Ly49H in KDY75/KDY75 mice. However, anti-
indicating that the integrity of genes flanking the tar- Ly49D mAbs were unable to trigger the lysis of the FcR1
geted KARAP/DAP12 gene was preserved in KDY75/ tumor target cells P815 by KDY75/KDY75 NK cells, in
KDY75 mice. KDY75/KDY75 mice were obtained at Men- contrast to results obtained with control NK cells
delian frequencies, developed normally, and were fertile. (Figure 2B, left panel). Ly49D has been recently shown
to be involved in the cytotoxicity exerted by mouse NKIn addition, no statistically significant variations in the
NK and DC Dysfunction in KARAP Mutant Mice
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cells against the xenogeneic target cells CHO (Idris et
al., 1999). Consistent with this result, the ability of NK
cells derived from KDY75/KDY75 mice to induce the
lysis of CHO cells was severely impaired as compared
to that of control NK cells (Figure 2B, right panel). How-
ever, the residual lysis of CHO cells by KDY75/KDY75
NK cells indicates that receptors distinct from Ly49D
might also be involved in this xenogeneic recognition.
Nevertheless, the signaling properties of Ly49D are
abolished in NK cells from KDY75/KDY75 mice, confirm-
ing that KARAP/DAP-12 ITAM is required for Ly49D acti-
vating properties.
The mechanisms that govern the shaping of the NK
cell repertoire of Ly49 molecules are unclear. It has been
proposed that activating NK receptors might contribute
to the regulation of inhibitory NK receptor expression
on NK cells. We thus analyzed in KDY75/KDY75 mice
the expression of Ly49A, C/I, and G2 as well as NKG2A/
NKG2C using available mAbs. As shown in Figure 2A,
no significant difference in the cell surface expression
of these receptors was observed when splenic NK cells
isolated from control and KDY75/KDY75 mice were com-
pared. Similar results were obtained when splenic NK
cells were cultured in vitro with IL-2 (data not shown).
Thus, no alteration of NK cell differentiation can be docu-
mented in KARAP/DAP12 loss-of-function mutant mice,
in which activating NK receptors for MHC class I mole-
cules are not functional.
Figure 3. Natural Cytotoxicity Exerted by NK Cells Isolated fromRestricted Natural Cytotoxicity Function
Control, KDY75/KDY75, and CD3z-FcRg2/2 Mice
in KARAP/DAP12 Knockin Mice
(A) Natural cytotoxicity exerted by splenocytes isolated from 8 hr
Natural cytotoxicity involves multiple natural cytotoxic- poly-IC-treated mice was assessed in a standard 4 hr 51Cr release
ity receptors (NCRs) expressed at the surface of NK assay against indicated target cell lines. Control mice, open circles;
cells. In humans, NCRs include Ig-like cell surface recep- KDY75/KDY75 mice, filled circles; CD3z-FcRg2/2 mice, filled tri-
angles.tors that are associated with ITAM-bearing polypep-
(B) Indicated mice were injected with poly-IC as described (Miyazakitides: NKp46 and NKp30 are associated with CD3z and/
et al., 1996). Freshly isolated DX51 cells were analyzed in a 4 hr 51Cror FcRg, whereas NKp44 is associated with KARAP/
release against indicated tumor cell lines. Control mice, open circles;
DAP12. In particular, NKp46 is mandatory for the lysis KDY75/KDY75 mice, filled circles. In similar experimental conditions,
of the mouse Bw15.02 target cell line by human NK no difference in the lysis of YAC-1 and RMA cell lines was observed,
cells. As the mouse NKp46 ortholog MAR-1 has been when KDY75/KDY75 DX51 cells and control DX51 cells were com-
pared (data not shown).described, we reasoned that in the mouse, MAR-1 asso-
ciates with CD3z and/or FcRg and that this oligomeric
complex is involved in the natural cytotoxicity of mouse
NK cell against Bw15.02. Control, KDY75/KDY75, and DAP12 is involved in NK cell natural cytotoxicity, de-
pending on the nature of the target cell lines. Thesemice genetically deficient for both CD3z and FcRg genes
(CD3z-FcRg2/2 mice) (Shores et al., 1998) were thus results also confirm that natural cytotoxicity involves
multiple NK cell surface receptors, which are engagedused as a source of NK cells to investigate the relative
contribution of KARAP/DAP12 and CD3z-FcRg in NK cell or not, depending on the cell surface expression of their
ligands on target cells. Along this line, severe naturalnatural cytotoxicity. No significant alteration of natural
cytotoxicity against YAC-1 and Bw15.02 was observed cytotoxicity defects against YAC-1, Bw15.02, RMA,
RMA/S (Figure 3A), as well as C4.4.25 (data not shown)when total splenocytes freshly isolated from control and
KDY75/KDY75 mice were compared (Figure 3A). The NK were observed when total splenocytes freshly isolated
from CD3z-FcRg2/2 mice were used as a source of NKcell natural cytotoxicity activities exerted against RMA
and its MHC class I2 variant RMA/S were also similar cells. The natural cytotoxicity function exerted by NK
cells derived from CD3z2/2 and FcRg2/2 mice againstbetween control and KDY75/KDY75 mice (Figure 3A).
Identical results were obtained using EL-4 and its MHC YAC-1 cells has been reported to remain intact (Liu et
al., 1993; Takai et al., 1994). Our data show that NK cellsclass I2 variant C4.4.25 (data not shown). By contrast,
the natural cytotoxicity function exerted by freshly iso- from CD3z-FcRg2/2 mice present a major deficiency in
natural cytotoxicity toward multiple tumor cell lines.lated KDY75/KDY75 DX51 splenocytes against the mac-
rophagic cell lines J774 and IC-21 was severely dimin- Therefore, CD3z and FcRg appear to exert redundant
function in natural cytotoxicity, contrasting with theished as compared to that observed with control DX51
cells (Figure 3B). These data thus indicate that KARAP/ mandatory function played by FcRg in ADCC (Takai et
Immunity
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al., 1994). Taken together, these results indicate that
CD3z-FcRg and KARAP/DAP12 do not exert redundant
function in NK cells but are associated with distinct
NCRs that are selectively involved in the natural cytotox-
icity toward cognate target cell lines.
Accumulation of DCs in Mucosal Tissues and Skin
in KARAP/DAP12 Knockin Mice
The expression of KARAP/DAP-12 in myeloid cells in-
cluding DCs (Bakker et al., 1999; Bouchon et al., 2000;
Dietrich et al., 2000; Tomasello et al., 2000) prompted
us to investigate whether the absence of a functional
KARAP/DAP12 molecule affected the distribution of
DCs present in lympho-epithelial tissues. Immunohisto-
chemical staining of DCs on cryostat sections of the
small intestine was carried out using anti-CD11c mAb
(N418), which recognizes both myeloid CD11b1 DCs and
lymphoid CD8a1 DCs (Iwasaki and Kelsall, 2000), and
anti-DEC205 mAb (NLDC-145), which reacts with inter-
digitating DCs from the T cell zone of lymphoid organs,
including Peyer’s patches (Kelsall and Strober, 1996).
In control mice, Peyer’s patch CD11c1 DCs formed a
layer of cells just beneath the epithelium, i.e., in the
subepithelial dome (SED) region, were present in the
interfollicular T cell region (IFR) and were also detected
as scattered cells in the follicle (Figure 4C). A limited
number of CD11c1 DCs were also present in the lamina
propria of the small intestinal villi (Figure 4A). KDY75/
KDY75 mice exhibited a 2-fold accumulation of CD11c1
Figure 4. Accumulation of DCs in Mucosal Tissues and Skin fromDCs in the intestinal lamina propria (Figure 4B): 2 6 0.8
KDY75/KDY75 MiceDCs/villus versus 4 6 0.6 DCs/villus for control and
Immunohistochemical analyses were performed in control mice (leftKDY75/KDY75 mice, respectively (n 5 4). A dramatic
panel: [A], [C], [E], [G], and [I]) and in KDY75/KDY75 mice (right
increase in CD11c1 DCs in the SED of Peyer’s patches, panel: [B], [D], [F], [H], and [J]). (A) to (D) CD11c staining of cryostat
but no detectable changes in interfollicular CD11c1 DCs, sections of small intestine (A and B) and Peyer’s patches (C and
were observed when control and KDY75/KDY75 mice D). (E) to (H) MHC class II staining of sections of buccal mucosa (E
and F) and abdominal skin (G and H). (I) and (J) DEC205 staining ofwere compared (Figure 4D). Both control and mutant
epidermal sheets. Counter staining was performed using hematoxy-mice presented comparable numbers of DEC2051 DCs,
lin (final magnification: 3400).The number and distribution of DCs inwhich were found primarily in the IFR but not in the SED
skin and mucosa of control mice was comparable in 129, C57BL/6,
(data not shown). Thus, KDY75 mutation was associated Balb/C mice and control mice (1/1 and 1/KDY75 littermates) (data
with increased numbers of CD11c1 DEC2052 DCs in not shown), therefore excluding that abnormal accumulation of DCs
small intestinal mucosa and SED of Peyer’s patches. in KDY75/KDY75 mutant mice merely resulted from a mixed genetic
background. The results are representative of data obtained in anMHC class II1 DCs, localized in the suprabasal layer of
average of 3 to 10 tissue sections from individual mice in groupsthe pluristratified epithelium as well as in the underlying
of three to five mice.dermis, represent the major antigen-presenting cell
(APC) population of the mouse buccal mucosa (Desvig-
nes et al., 1998). Since buccal epithelial DCs, similarly class II1 DCs infiltrating the dermis of KDY75/KDY75
mice were CD11b1 cells (data not shown). To furtherto epidermal Langerhans cells, express high levels of
MHC class II molecules but are weakly positive for determine whether KARAP/DAP12 loss-of-function mu-
tation affected the number of epidermal DCs in the skin,DEC205 and CD11c, DCs were identified in sections of
both buccal mucosa and abdominal skin by staining for epidermal sheets from the ears were stained with anti-
MHC class II, anti-DEC205, and anti-CD11c mAbs. AllMHC class II and by their typical dendritic morphology.
A dramatic accumulation of MHC class II1 cells with mAbs decorated a network of epidermal Langerhans
cells of similar density in both control and mutant micedendritic morphology was observed in the buccal mu-
cosa of KDY75/KDY75 as compared to control mice: (Figures 4I and 4J; data not shown). This result indicates
that in the absence of a functional KARAP/DAP12 mole-14.5 6 2.4 versus 4.5 6 0.5 DCs/mm2, respectively (n 5
4) (Figure 4F). Similarly, the number of MHC class II1 cule, the abnormal accumulation of DCs in pluristratified
epithelial tissues, such as the buccal mucosa and thecells with dendritic morphology was increased in
KDY75/KDY75 skin, as compared to control skin: 32.0 6 skin, affected primarily the dermis. No significant
changes in the distribution and density of DCs in spleen7.0 versus 10.8 6 2.5 DCs/mm2 respectively (n 5 3).
Staining of serial sections of the buccal mucosa with and in peripheral lymph nodes could be detected in
KDY75/KDY75 mice (data not shown). Taken together,anti-MHC class II and anti-CD11b mAb revealed that, in
contrast to control mice in which CD11b1 cells were these data indicate that the KARAP/DAP12 loss-of-func-
tion mutation results in the accumulation of DCs (andbarely detectable in the dermis, the majority of MHC
NK and DC Dysfunction in KARAP Mutant Mice
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Figure 5. Phenotypic and Functional Analy-
sis of BM-DCs from KDY75/KDY75 Mice
BM-DCs were differentiated in vitro from bone
marrow progenitors in the presence of GM-
CSF. On day 6 of culture, LPS (10 ng/ml) was
added to some wells and cells were analyzed
on day 7.
(A) Phenotypic analysis of untreated (upper
panels) or LPS-treated (lower panels) BM-
DCs from control mice and KDY75/KDY75
mice were carried out by flow cytometry. The
percentages of positive stained cells (contin-
uous lines) as well as the control staining us-
ing isotype-matched control mAbs (dotted
lines) are indicated.
(B) Allostimulatory function of KDY75/KDY75
BM-DCs for CD41 T cells was carried out by
cocultivation of untreated or LPS-treated
BM-DCs (4 3 103/well) from either control
(open circles) or KDY75/KDY75 (filled circles)
mice, with purified allogeneic CD41 T cells
(105/well) for 4 days. The results are expressed
as mean cpm 6 SD of quadruplicate cultures.
possibly pre-DCs) of myeloid origin in mucosal tissues, and KDY75/KDY75 mice to stimulate proliferation of allo-
geneic CD41 T cells. As shown in Figure 5B (left panel),without detectable changes in distribution or phenotype
of DCs in secondary lymphoid organs. as few as 4 3 103 BM-DCs from either control or KDY75/
KDY75 mice stimulated a strong proliferative response
of allogeneic CD41 T cells. Moreover, LPS-induced mat-
Phenotype and Function of Bone Marrow–Derived uration of BM-DCs of either control or KDY75/KDY75
DCs in KARAP/DAP12 Knockin Mice mice resulted in similar enhancement of their allostimu-
The selective accumulation of DCs observed in KDY75/ latory capacity (Figure 5B, right panel). Thus, BM-DCs
KDY75 mice might be the consequence of abnormal DC derived from KDY75/KDY75 mice exhibited a normal
differentiation. To directly test this hypothesis, DCs were maturation pathway associated with potent allostimula-
differentiated in vitro from bone marrow progenitors in tory property for naive CD41 T cells, characteristic of
the presence of GM-CSF. Flow cytometric analysis of DCs.
day 7 bone marrow–derived DCs (BM-DCs) from control
and KDY75/KDY75 mice, revealed a similar phenotype
consisting of 50% to 60% CD11c1CD11b1 cells, charac- Function of Myeloid Epithelial DCs in KARAP/DAP12
Knockin Miceteristic of myeloid DCs, expressing low levels of DEC205,
CD80 and CD86 (Figure 5A, upper panels) (Inaba et al., Epithelial myeloid DCs have the capacity to migrate to
draining lymph node upon antigen capture in the epithe-1992). Double staining of BM-DCs confirmed that both
CD11c1 DCs and CD11b1 DCs coexpressed MHC class lium (reviewed in Banchereau et al., 2000). To directly
test the migratory capacity of skin DCs from KDY75/II molecules (data not shown). Moreover, 24 hr LPS-
stimulation of BM-DCs induced similar maturation of KDY75 mice to draining lymph nodes, KDY75/KDY75
mice and 1/1 littermates were skin-painted with theDCs from both mutant and control mice as shown by
up-regulation of cell surface expression of MHC class fluorescent hapten FITC. In control mice, 7%–12% of
FITC1 cells were found in the draining lymph nodes 24II, DEC205, CD80, and CD86 molecules (Figure 5A, lower
panels). To determine whether DCs differentiated from hr after skin painting with FITC. The draining lymph node
of KDY75/KDY75 mice contained 8%–25% of FITC1KDY75/KDY75 mice were functional, we next investi-
gated the ability of BM-DCs prepared from either control cells. Double staining of lymph node cells for MHC class
Immunity
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CD16 associated with CD3z and/or FcRg (Vivier et al.,
1991a; Takai et al., 1994). Both ADCC and natural cyto-
toxicity thus appear dependent upon ITAM-bearing poly-
peptides on freshly isolated NK cells, providing the basis
for the pharmacological inhibition of ADCC and natural
cytotoxicity by PTK inhibitors (O’Shea et al., 1992).
ITAM-bearing polypeptides couple the engagement
of associated cell surface receptors to PTK-dependent
pathways. When phosphorylated on ITAM tyrosine resi-
dues, ITAM-bearing polypeptides recruit the SH2-tan-
dem PTKs, Syk and/or ZAP-70 (reviewed in Chu et al.,
1998). In vitro studies have shown that phosphorylation
of both tyrosine residues present in ITAM are mandatory
to the recruitment and activation of Syk and ZAP-70.
These results are supported by the low affinity of eachFigure 6. Impaired CS to DNFB in KDY75/KDY75 Mice
SH2 domain for single tyrosine phosphorylated hemi-Control mice (open circles) and KDY75/KDY75 mice (filled circles)
were sensitized with 0.5% DNFB and challenged 5 days later onto ITAM, as well as by the spatial arrangement of the N
the right ear with 0.2% DNFB; the left ear received the vehicle and C terminus SH2 domain of ZAP-70 that precisely
alone. CS was determined by the increase in the thickness of the fits the length of the spacer between each tyrosine resi-
challenged ear (expressed in mm). Medians 6 SD are indicated. dues in ITAMs (Chu et al., 1998). Along this line, we
previously reported that mutation of a single tyrosine in
KARAP/DAP12 ITAM prevents KARAP/DAP12-depen-II or CD11b showed that in both control and KDY75/
dent activation of transfected cell lines (Tomasello etKDY75 mice all FITC1 cells present in the draining lymph
al., 1998). Our present data provide formal evidencenode were MHC class-IIhigh and CD11b1 (data not
that both tyrosine residues in KARAP/DAP12 ITAM areshown). Thus, the migratory capacity of skin DCs ap-
required for KARAP/DAP12 transduction function. Thesepeared normal in KDY75/KDY75 mice.
results thus support the critical role of SH2-tandemContact sensitivity (CS) is a T cell mediated inflamma-
PTKs Syk and/or ZAP-70 as single effector moleculestory skin reaction in response to topical application of
downstream of KARAP/DAP12. The role of Syk as ahaptens, initiated by hapten capture by skin DCs, which
preferential downstream effector molecule for KARAP/migrate to the paracortical area of draining lymph node
DAP12 has been reported (McVicar et al., 1998). In addi-and prime hapten-specific T cells. Challenge of hapten-
tion, Syk has been shown to be mandatory for NK cellsensitized mice with the same hapten at a remote skin
natural cytotoxicity in cell lines (Brumbaugh et al., 1997).site (ear) induces recruitment of hapten-specific CD81
However, NK cells derived from Syk2/2 or ZAP2/2 miceeffector T cells, which initiate the inflammatory reaction
as well as from ZAP-deficient patients have been re-and edema of the skin (Kehren et al., 1999). Thus, CS
ported to be fully competent for natural cytotoxicity (El-
to 2,4-dinitrofluoro-benzene (DNFB) was used to investi-
der et al., 1994; Negishi et al., 1995; Colucci et al., 1999).
gate the in vivo function of skin DCs from KDY75/KDY75
Taken together, these results suggest that in vivo Syk
mice. CS to DNFB was severely impaired in KDY75/
and ZAP-70 subserve redundant functions in NK cells.
KDY75 mice, as compared to control mice (Figure 6). Formal demonstration of this compensatory signaling
These results thus suggest that skin DCs from KDY75/ pathway will require the generation of Syk-ZAP2/2
KDY75 mice are unable to prime hapten-specific CD81 mouse NK cells.
T cells responsible for the CS response. Moreover, CS Another direct consequence of our findings is that
to DNFB develops similarly in C57Bl/6, 129 and Balb/c NK cell surface molecules involved in NK cell cytotoxic
(data not shown) excluding a mixed genetic background function (e.g., CD2, DNAM-1) that are not physically as-
effect in the CS impairment observed in KDY75/KDY75 sociated with ITAM-bearing polypeptides might rather
mice. serve as coreceptors for NK cell cytotoxicity than as
initiating NCRs, as it has been recently reported for 2B4
Discussion (Sivori et al., 2000). The functional link between CD2
engagement and CD3z tyrosine phosphorylation (Vivier
ITAM-Dependent NK Cell Natural Cytotoxicity et al., 1991b) supports this hierarchical organization of
In mouse NK cells, KARAP/DAP12 dimers associate with NK cell surface receptors. Similar conclusions may be
activating Ly49 molecules (e.g., Ly49D, Ly49H, Ly49P). drawn for mouse LAG-3. Although not detected on hu-
NK cells express CD3z and FcRg polypeptides, and it man NK cells (data not shown), LAG-3 is expressed
has been described that Ly49D may associate with CD3z on mouse NK cells, and NK cells from LAG-32/2 mice
in transfected cell lines (Ortaldo et al., 1999). Our results present deficient natural cytotoxicity toward selected
show that no activation signal through Ly49D could be tumor cell lines including the macrophagic J774 and IC-
detected in KDY75/KDY75 mice, indicating that Ly49D 21 cell lines (Miyazaki et al., 1996). NK cells from KDY75/
only functionally associates with KARAP/DAP12 in vivo. KDY75 mice are also deficient in their natural cytotoxicity
Together with the drastic impairment of NK natural cyto- toward J774 and IC-21 cell lines. A direct physical inter-
toxicity in CD3z-FcRg2/2 mice, our results on KDY75/ action between LAG-3 and KARAP/DAP12 in mouse NK
KDY75 mice reveal the importance of ITAM-bearing mol- cells cannot be ruled out but would be unexpected due
ecules in natural cytotoxicity. In NK cells, antibody- to the absence of transmembrane charged amino acid
residues in LAG-3. Therefore, our results suggest thatdependent cell cytotoxicity (ADCC) is mediated via
NK and DC Dysfunction in KARAP Mutant Mice
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LAG-3 might serve as a KARAP-dependent coreceptor in the SED of Peyer’s patches (Cook et al., 2000), respon-
sive to MIP-3a produced by the dome epithelium (Iwa-for natural cytotoxicity in mouse NK cells.
saki and Kelsall, 2000), suggests that KARAP/DAP12
may be involved in DC responsiveness to chemokines
Shaping of the NK Cell Repertoire of Ly49 Molecules produced by mucocutaneous epithelia. Lack of func-
During NK cell development, an MHC-dependent educa- tional KARAP/DAP12 also results in abnormally high num-
tion operates for the formation of the Ly49 repertoire bers of MHC class II1 and of CD11b1 cells with dendritic
(Held and Raulet, 1997). It has been thought that if MHC morphology in skin and buccal mucosa dermis. These
specificities are similar for activating and inhibitory Ly49 cells could be either myeloid DCs or activated monocytes/
isoforms, then activating Ly49 molecules may serve in macrophages entering the dermis from the blood. Indeed,
an MHC-dependent selection. All known activating iso- activated monocytes extravasating through endothelial
forms of classical and nonclassical MHC class I recep- cells may either become resident macrophages or differ-
tors (Ly49 and CD94/NKG2 molecules) associate with entiate into DCs upon emigration from the tissue through
KARAP/DAP12. Therefore, KDY75/KDY75 mice repre- afferent lymph (Randolph et al., 1998, 1999).
sent loss-of-function mutants for all activating MHC
class I receptors. The shaping of the NK cell repertoire Concluding Remarks
of MHC class I receptors appears unaltered in KDY75/
Taken together, our data strongly support the hypothe-
KDY75 mice, as judged by mAb staining, as well as by
sis as which signaling through KARAP/DAP12 plays a
the capacity of KDY75/KDY75 NK cells to distinguish
critical role in the differentiation and/or activation pro-
RMA and EL4 cell lines from their MHC class I2 variants
grams of myeloid DCs/pre-DCs within epithelia. The cell
(RMA/S and C4.4.25 cell lines, respectively). Our present
surface receptors associated with KARAP/DAP12 that
results thus strongly suggest that the shaping of the NK
are responsible for these pathways remain to be identified
cell repertoire of inhibitory MHC class I receptors does
and may include SIRPb1, MDL-1, TREM-1, or TREM-2. It
not depend upon the function of their activating iso-
will also be important to investigate whether KARAP/
forms. Consistent with these data, it has been recently
DAP12-deficient patients, which develop the Polycystic
shown that Ly49D and Ly49H activating molecules are
Lipomembranous Osteodysplasia with Sclerosing Leu-
expressed later in NK cell development than the inhibi-
koencephalopathy (PLOSL) (Paloneva et al., 2000), pre-
tory receptors (Smith et al., 2000).
sent abnormalities within the myeloid compartment and
whether such alterations are related to the PLOSL
pathogenesis. Finally, the impaired CS to DNFB inMyeloid Abnormalities in Absence
KDY75/KDY75 mice suggests an inadequate priming ofof Functional KARAP/DAP-12
hapten-specific CD81 T cells (Tc1 effector) mediatingDCs represent an unique APC type by their ability to
tissue inflammation (Kehren et al., 1999). Indeed, IL-12prime naive T cells after antigenic capture from periph-
secretion by myeloid DCs is mandatory for priming IFNgeral tissues and migration to draining lymph node
secreting CS effector T cells and for the development(Banchereau et al., 2000). In the small intestine of wild-
of the skin inflammatory response (Mu¨ller et al., 1995).type mice, CD11c1 DCs reside in three distinct anatomi-
Along this line, KARAP/DAP-12-deficient mice also failcal sites. Few DCs are present in the lamina propria of
to develop the Th1-mediated experimental autoimmunethe villi. DCs also form a dense layer beneath the SED
encephalitis induced by myelin oligodendrocyte glyco-of Peyer’s patches. Finally, DCs can be found as mature
protein peptide immunization (data not shown; Bakkerinterdigitating cells in the IFR of Peyer’s patches (Kelsall
et al., 2000). It thus remains to determine whether andand Strober, 1996). Recent studies showed that the
how the accumulation of myeloid DCs/pre-DCs in epi-CD11c1DEC2052 DCs that are located in the SED region
thelia is linked to the deficient Tc1 and Th1 primingof Peyer’s patches and in the lamina propria are CD11b1
observed in the absence of a functional KARAP/DAP12myeloid DCs, while CD11c1 DEC2051 DCs within the
signaling pathway.IFR are CD8aa1 lymphoid DCs (Iwasaki and Kelsall,
2000). SED DCs as well as lamina propria DCs may
Experimental Procedurescapture oral antigens translocating through the M-cell
rich epithelium of Peyer’s patches or through absorptive Mice
villus epithelial cells, respectively, and activate T cells C57BL6, Balb/c, 129, and CBA mice were from Jackson laboratories.
either locally in the Peyer’s patches or after migrating C57BL6 mice transgenic for Cre recombinase gene controlled by a
CMV promoter were kindly provided by K. Rajewsky. C57BL6 CD3z-through mesenteric lymph in the draining mesenteric
FcRg2/2 double knockout mice have been previously describedlymph nodes.
(Shores et al., 1998). All mice were reared under specific-pathogenKARAP/DAP12 is present in DCs (Bakker et al., 1999;
free animal facilities. Control mice include 1/1 and 1/KDY75 lit-
Bouchon et al., 2000; Dietrich et al., 2000; Tomasello et termates, for which no significant phenotypic and functional differ-
al., 2000), including BM-DCs (data not shown), and lack ences were detected.
of signaling through KARAP/DAP12 ITAM causes a dra-
matic accumulation of DCs that reside in lympho-epithe- Generation of KDY75/KDY75 Mice
An EcoRI/XhoI-digested genomic fragment of 8.8 kb containinglial tissues. In the intestine, KDY75/KDY75 mice exhib-
mouse KARAP/DAP12 gene (Tomasello et al., 1998) was subclonedited a major increase in the number of CD11c1DEC2052
in pBlueScript KS plasmid. A neo-resistance cassette flanked byDCs in the lamina propria of the mucosal villi, as well
two lox P sites was inserted at the unique XcaI restriction site. The
as in the SED, but not in the IFR of Peyer’s patches. first loxP sequence is 59 of the KARAP/DAP12 sequence corre-
The recent finding that CCR6-deficient mice exhibit a sponding to the second YxxL within KARAP/DAP12 ITAM. This inser-
tion generated the mutant KARAP/DAP12 gene (KDY75) encodingselective defect in the CD11c1CD11b1 subset of DCs
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a KARAP/DAP12 protein in which the wild-type C-terminal Y75-R86 dilution) and control isotypes including hamster IgG were from Phar-
mingen or ATCC. Endogenous peroxidase was blocked by treatingamino acid stretch (YSDLNTQRQYR) is replaced by a G75-I90 peptide
tissue sections with 0.3% H2O2, prior to incubation with the primary(GLQEFIEDEKKKRNSI), with no homology with any peptide se-
antibodies. In other experiments, epidermal sheets from ear skinquences in the databases. 129 Ola ES (E14) cells were transfected
were incubated overnight at 48C with specific or control isotypeby electroporation with the linearized targeting construction and
matched mAb. Specific staining of cryostat sections and epidermalES clones were selected by Southern blot. Recombinant progeny of
sheets was revealed using biotinylated mouse adsorbed F(ab9)2 frag-chimeric mice was mated with C57BL/6 Cre transgenic mice. 1/KDY75
ment of goat anti-rat IgG (Vector, Biosys, France) or goat F(ab’)2heterozygous neo-excised progeny were backcrossed to obtained
anti-hamster IgG (H1L) (Pierbio Science, France), followed by strep-homozygous KDY75/KDY75 mutant mice. Sequence analysis of RT-
tavidin conjugated to peroxidase (Amersham, France). The reactionPCR products obtained from KDY75/KDY75 splenocytes confirmed
was developed using AEC substrate and H2O2 (AEC kit, Dako), andthe replacement of the wild-type KARAP/DAP12 Y75-R86 C terminus
the tissue sections were counterstained with hematoxylin (Dako).by the predicted G75-I90 peptide.
DC were counted from 3 to 10 tissue sections of individual mice
using a microscopic grid and the results expressed as number ofSouthern Blot and RT-PCR Analysis
DCs/mm2 of tissue (skin and buccal mucosa) or number of DCs/Genomic DNA extracted from tails of KDY75/KDY75 mice was cut
intestinal villus.with EcoRI enzyme and analyzed by Southern blot using radiola-
beled 0.4 kb XhoI/EcoRI fragment as probe E. Total RNA was ex-
BM-DCstracted from splenocytes of KDY75/KDY75 mice and converted in
BM-DCs were generated from bone marrow progenitors, as pre-cDNA as previously described (Tomasello et al., 1998). cDNA was
viously described (Inaba et al., 1992), with modifications. In brief,then tested by RT-PCR using the following primers:
bone marrow was flushed from tibias and femurs prior to red bloodb-actin forward (59-TACCACTGGCATCGTGATGGACT-39); b-actin
cell depletion using 0.83% ammonium chloride. Cells were culturedreverse (59-TCCTTCTGCATCCTGCGGCAAT-39); KARAP/DAP12 for-
at 378C in 24-well culture plates (2 3 105 cells/ml/well) in completeward (59-ACTTTCCCAAGATGCGAC-39); KARAP/DAP12 reverse
RPMI medium supplemented with 40 ng/ml of recombinant murine(59-GTACCCTGTGGATCTGTA-39); DAP10 forward (59-ATGGACCC
GM-CSF (Peprotech, France). Half of the medium was replacedCCCAGGCTACCTC-39); and DAP10 reverse (59-TCAGCCTCTGCC
every other day by fresh medium and GM-CSF. On day 6 of culture,
AGGCATGTT-39).
BM-DCs were stimulated for 24 hr at 378C with E. coli LPS (10 ng/
ml, Sigma, La Verpillie`re, France). Loosely attached BM-DCs were
Cells harvested on day 7, washed twice in PBS containing 1% BSA and
YAC-1, RMA, RMA-S, EL4, C4.4.25 cell lines were kindly provided 0.01% sodium azide, and then stained with the following antibodies:
by H-G. Lju¨nggren (Karolinska Institutet, Sweden). Bw15.02 cell line FITC-conjugated hamster anti-mouse CD11c mAb (HL-3), FITC- or
was kindly given by A. Moretta (University of Genova, Italy). J774 biotin-conjugated CD11b mAb (M1/70), PE-conjugated MHC class
and IC21 were a kind gift from C. Benoist (Joslin Diabetes Center, II mAb (M5/114, a rat mAb anti-IAb/d/q, I-Ed/k), FITC-conjugated CD86
Boston). All cell lines were cultured in RPMI 1640 10% FCS with mAb (GL-1), and FITC-conjugated hamster anti-mouse CD80 (16–
sodium pyruvate (1 mM) and b-mercaptoethanol (5 3 1025 M). 10A1), all from Pharmingen. DEC205 (NLDC-145) was used as cul-
IL-2-activated killer cells were obtained as follows: freshly isolated ture supernatant from Biotest. Control isotypes included FITC-con-
splenocytes were incubated with MACS DX5-coupled beads (Mil- jugated hamster IgG and PE- or FITC-conjugated rat IgG2aK
tenyi) and then subjected to positive selection. Collected DX51 cells (Pharmingen). DEC205 staining was revealed using mouse-adsorbed
were cultured for 7 days in RPMI 10% FCS with sodium pyruvate FITC-conjugated F(ab9)2 goat antibody specific for rat IgG (H1L)
(1 mM), b-mercaptoethanol (5 3 1025 M), nonessential MEM amino (Caltag Laboratories). Before staining, Fc receptors (FcgRII/III) were
acids, Hepes (10 mM), and 1000 UI/ml of IL-2 (Chiron). blocked using either 5% normal mouse serum or rat anti-mouse
CD16/CD32 (2.4.G2) for 30 min on ice. Samples were analyzed using
a FACStar and Lysis II software (both from Becton Dickinson).Antibodies
The following mAbs were obtained from Pharmingen-Becton Dickin-
Allogeneic Mixed Lymphocyte Reactionson: APC-conjugated anti-CD3e (2C11, hamster IgG1), PE-conju-
Untreated and LPS-treated day 7 BM-DCs were treated with 25 mg/gated DX5 (DX5, Rat IgM), FITC-conjugated anti-Ly49D (4E5, rat
ml of mitomycin C and cocultured in quadruplicate wells of round-IgG2a), FITC-conjugated anti-Ly49C/I (5E6, mouse IgG2a), and
bottomed microculture plates with 105 CD41 T cells purified fromFITC-conjugated anti-Ly49G2 (4D11, rat IgG2a). FITC-conjugated
CBA mice spleen using MACS anti-CD4-coupled microbeads (Mil-anti-Ly49H (3D10, mouse IgG1) was kindly provided by W. M. Yoko-
tenyi, France). On day 3 of coculture, 1 mCi [3H] thymidine (specificyama and H. R. Smith (St. Louis, MO). Purified anti-Ly49D (4E5,
activity 1 Ci/mM) was added to each well, and T cell proliferationrat IgG2a) and anti-NKG2A/C (20D5, rat IgG2a) mAbs have been
was determined by tritiated thymidine incorporation during the lastpreviously described (Mason et al., 1998; Vance et al., 1999). Anti-
24 hr of culture. The cultures were harvested with an automatic cellLy49A mAbs (JR9.318, mouse IgG1) were a kind gift from J. Roland
harvester and radioactivity was counted using a b plate counter(Institut Pasteur de Paris). Isotype-matched control mAbs were pur-
(Wallac). The results are expressed as mean cpm 6 SD in quadrupli-chased from Pharmingen.
cate wells.
Cytotoxicity Assay
Contact Sensitivity
Mice were injected i.p. with 150 mg/mouse of polyinosinic:cytidylic CS to DNFB was determined by the mouse ear swelling test (MEST),
acid (poly I:C, Sigma) 8 to 48 hr prior to sacrifice, and freshly isolated as previously described (Desvignes et al., 1996). In brief, mice were
splenocytes were used as effector cells. Alternatively, IL-2-activated sensitized epicutaneously on day 0 by application of 0.5% DNFB
DX51 purified splenocytes were tested after 7 days of culture in IL-2. (25 ml) diluted in acetone/olive oil (4/1, v/v) onto 2 cm2 of shaved
Effector cells were used in a standard 4 hr 51Cr cytotoxicity assay abdominal skin. On day 5 after sensitization, mice were challenged
(Olcese et al., 1997). For Ly49D-redirected killing, IL-2-activated onto the right ear by topical application of 0.2% DNFB, whereas
cells were tested against the tumor cell line P815 in the presence the left ear received the vehicle alone (acetone/olive oil). Contact
of 5 mg/well of purified anti-Ly49D mAbs. sensitivity was determined by increase in the thickness of the chal-
lenged ear compared with that of control left ear and was expressed
Immunohistochemical Analysis in mm: (T-To of the right ear) – (T-To of the left ear), where T and
Cryostat sections (5 mm) of various tissues were acetone fixed and To represent the values of ear thickness after and before challenge,
stained using hamster anti-mouse CD11c mAb (N418, ATCC) as respectively.
neat supernatant, rat anti-mouse mannose receptor mAb DEC205
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